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Introduction Methods Results Conclusion 
European poultry sector 
 In 2016 the EU produced 14.3 million tonnes of poultry meat and 7.8 
million tonnes of eggs 
 Poultry meat production systems are fairly efficient and well-
controlled and this is important in order to maintain and improve the 
competitiveness of the sector in the international market 
 Controlling production diseases and bird health is an important part 
of the competitiveness especially in intensive production systems 
 Only sporadic studies on the costs of poultry production diseases 
exists, saying for instance that  
….Necrotic enteritis can cost globally €2 to €5 billion per year  
…. €3 billion is spent each year worldwide for coccidiosis prevention 
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The economic impacts of diseases on farms fall into four areas 
 The incidence, severity and costs of disease can vary by case  
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Revenues and production foregone 
Extra production costs
Saved production costs
Additional revenues
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Preventive measures also incur costs, and they are  
incurred before observing potential benefits 
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Costs of adoption 
• Additional labour needed 
• Extra materials 
• Effects on farm operations… 
Benefits 
• Lower veterinary and 
medication costs 
• Improved yield 
• Increased homogeneity 
• Better product quality…. 
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Good disease management decision making requires data 
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 Recognize the risks posed by various production diseases, their 
incidence and severity 
 Availability and efficacy of control and prevention measures 
 The economic impacts of diseases and benefits/disbenefits arising 
from the use of interventions 
 
Systematic review of 127 studies on selected production diseases 
Standard cost calculations and modelling disease interventions 
Consultation of 45 stakeholders (vets, transporters, abattoirs, 
processors, retailers) in Finland, Germany, Poland, Spain & UK 
Surveys conducted among citizens in five countries 
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How costly are production diseases? 
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The incidence of the production diseases in reviewed studies 
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Note: Incidence = % of flocks with disease at a severity to cause economic losses 
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Impacts 
 Application of physical impacts on bird performance (growth, yields, 
feed consumption, mortality, downgrades, treatment costs) to the 
standard broiler and layer cost models 
 Excluded costs:  
   additional carcass disposal costs 
   additional vet/ medicine costs  
   labour costs for increased monitoring/inspection 
 
 Losses are higher for laying hens because diseases are impacting 
over a longer production period  
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Economic losses (€/surviving bird) due to four  
controlled/uncontrolled production diseases in broilers 
 Commercial broiler profit in 2013 was about 10 cents per bird 
Most efficacious interventions reflected (high-end of what can be 
acheived) 
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Economic losses (€/surviving bird) due to four  
controlled/uncontrolled diseases in laying hens 
 Laying hens typically generated a margin of around €10 per bird 
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Did the stakeholders agree with the estimated  
economic losses? 
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Modelling impacts of interventions to control  
foot pad dermatitis in broilers (€ per 10 000 birds unit) 
 Preliminary results on measures to reduce the prevalence of FPD 
(€4546 per 10 000 birds unit, 35% prevalence) 
 Some interventions* are attractive on €/kg meat basis 
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Which interventions do stakeholders prefer  
to control for production diseases (in general)? 
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Over 80% respondents preferred
• Enhanced biosecurity and hygene
• Ehanced control of ventilation
• Enhanced litter quality
• Vaccination
• Adjustment to feed composition
40-80% respondents preferred
• Re-designed housing
• Changes in light regime
• Provision of play materials
• Adjust quantity of feed available
Less than 40% respondents preferred
• Preventive medication
• Use antimicrobials and other medicines
• Doing nothing (none preferred this)
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The public prefer proactive strategies 
 Enhanced hygiene and disease prevention 
 Conditions where animals can perform natural behaviours 
 Housing that allows birds greater freedom to move 
 Reducing the number of animals in a given area 
 Improvements in housing design 
 
 The use of vaccination 
 Adjustments to the quantity of feed available 
 Using antibiotics and medicines to treat sick animals 
 Use of feed supplements e.g. probiotics 
 The preventative use of veterinary drugs 
 Doing nothing 
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(interventions listed in between are not shown) 
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Sector-level aspects 
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Market-clearing price & quantity 
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New supply 
Risk is a cost! If a production 
disease becomes wide-spread, 
and production costs may rise 
and the markets may seek for a 
new equilibrium 
Wider economic impacts 
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What about societal acceptance? 
 Public acceptance is an important part of sustainability 
 Benefits of intensive production systems (e.g. resource and cost 
efficiency) are acknowledged by the public, but they also have 
concerns in relation to animal welfare, antibiotic use and food safety  
 The public appear to have little knowledge of production diseases and 
their mitigation strategies  Proactive provision of information 
 Consumers associate animal friendly products with improved product 
quality, safety and healthiness 
 The willingness to pay more for safer and animal-friendlier products 
varies  
 Tendency to prefer natural and proactive interventions to control for 
production diseases ― reactive and “treatment-based” interventions 
are viewed as less acceptable 
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Concluding remarks 
 Production diseases can cause major economic losses to poultry 
farms if not controlled effectively 
 Economically viable interventions exist 
 Emphasis on preventive measures 
 Current literature on economic impacts and economics of controlling 
production diseases is limited 
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